To see how cfRNA levels change across different mutational subgroups, our further statistical analysis took into consideration the mutational status of melanoma patients, distinguishing between BRAF/NRAS wild‐type (N = 25) (Figure 6E–H) and BRAF or NRAS mutant (N = 56) cohorts (Figure 6I–L). The gene discussed is NRAS; the disease is melanoma.